Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RITUXIMAB-PVVR Cause Post procedural complication? 8 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Post procedural complication have been filed in association with RITUXIMAB-PVVR. This represents 0.2% of all adverse event reports for RITUXIMAB-PVVR.

8
Reports of Post procedural complication with RITUXIMAB-PVVR
0.2%
of all RITUXIMAB-PVVR reports
0
Deaths
6
Hospitalizations

How Dangerous Is Post procedural complication From RITUXIMAB-PVVR?

Of the 8 reports, 6 (75.0%) required hospitalization, and 1 (12.5%) were considered life-threatening.

Is Post procedural complication Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RITUXIMAB-PVVR. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does RITUXIMAB-PVVR Cause?

Off label use (2,079) Intentional product use issue (627) Condition aggravated (514) Death (338) Covid-19 (322) Fatigue (318) Dyspnoea (314) Inappropriate schedule of product administration (311) Headache (291) Pruritus (288)

What Other Drugs Cause Post procedural complication?

ADALIMUMAB (2,494) ETANERCEPT (318) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (244) UPADACITINIB (241) RISANKIZUMAB-RZAA (232) INFLIXIMAB (217) METHOTREXATE (188) TREPROSTINIL (174) HUMAN IMMUNOGLOBULIN G (159) PREDNISONE (157)

Which RITUXIMAB-PVVR Alternatives Have Lower Post procedural complication Risk?

RITUXIMAB-PVVR vs RIVAROXABAN RITUXIMAB-PVVR vs RIVASTIGMINE RITUXIMAB-PVVR vs RIVOTRIL RITUXIMAB-PVVR vs RIZATRIPTAN RITUXIMAB-PVVR vs ROACTEMRA

Related Pages

RITUXIMAB-PVVR Full Profile All Post procedural complication Reports All Drugs Causing Post procedural complication RITUXIMAB-PVVR Demographics